Osteoporosis care at risk in the U.S.
Virginia Tech Intellectual Properties (VTIP) announces that the US Patent and Trademark Office has granted a patent for targets and methods to develop new drugs for malaria. For decades, scientists have been searching for a way to target malaria-causing parasites that have infected the human body. Researchers from the Virginia Biotechnology Institute (VBI) at Virginia
Full Post: U.S. patents granted to Virginia Tech for targets and methods to develop new drugs for malaria
Cuts to Medicare reimbursement of DXA undermine efforts to properly diagnose and treat osteoporosis and diminish quality of patient care.
According to a paper published in the November issue of the Springer journal Osteoporosis International, Medicare reimbursement for dual-energy X-ray absorptiometry (DXA) has been cut to levels substantially below the cost to perform the procedure. As a result, many physicians and clinics around the country are likely to discontinue this critical health service - greatly limiting the public’s access to the test and jeopardizing those at risk for a fracture.
The reimbursement cuts run contrary to existing federal initiatives already in place to increase fracture prevention efforts and improve the prevention, diagnosis and treatment of osteoporosis.
The article shows that DXA is a key tool in identifying those at risk for osteoporosis and helping those with the disease monitor their bone health. It is a recognized tool for preventing and reducing costly fractures, which account for $18 billion in national healthcare costs and are projected to increase by 50 percent over the next two decades, reaching $25.3 billion in 2025.
The authors of the article, E.M. Lewiecki, S. Baim and E.S. Siris, stated their support for “?federal efforts to contain healthcare costs and eliminate unnecessary medical services.” However, with the Medicare cuts in reimbursement, “fewer patients at high risk for fracture will be identified and fewer patients will be treated. As a result, there will be more osteoporotic fractures.”
The article cites a recent study completed by The Lewin Group, which found that restoring DXA reimbursement to the 2006 levels would save the Medicare program $1.14 billion over five years due to the reduced number of osteoporotic fractures.
Osteoporosis now causes an estimated 2 million fractures each year and often results in immobility, pain, placement in a nursing home, isolation and other health problems-conditions and circumstances that could largely be prevented through proper bone density testing and diagnosis.
A new method for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by The National Osteoporosis Guideline Group in the UK. Rather than relying primarily on Bone Mineral Density (BMD) measurements, as the majority of current guidelines do, their approach takes into account
Full Post: Better targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide
If you will exert too much pressure on a bone, more than the threshold pressure which it can tolerate, it will break. This is usually termed as bone fracture and is a very painful thing. Fractures are considered as a major form of injury. However, whether a person can recover from them depends on a
Full Post: Symptoms of a fracture
New research reveals that computed tomography (CT) colonography, also known as virtual colonoscopy, has the potential to screen for two diseases at once-colorectal cancer and osteoporosis, both of which commonly affect adults over age 50. Results of the study will be presented today at the annual meeting of the Radiological Society of North America (RSNA).
Full Post: Virtual colonoscopy has potential to screen for colorectal cancer and osteoporosis at same time
Patients who start and eventually stop regimens of a common class of osteoporosis drugs called bisphosphonates may be unable to benefit from parathyroid hormone (PTH), which can rebuild bone mass lost due to advanced stage osteoporosis. PTH has been proven to increase the volume and strength of the honeycomb-like bone infrastructure, the inner mesh that
Full Post: Osteoporosis drugs may prevent future bone growth
Men who survived childhood leukemia treatment into adulthood were more likely to have low bone mineral density than other adults their age, putting them at risk of osteoporosis and bone fractures, according to a new study. The study, led by James G. Gurney, Ph.D., of the University of Michigan Comprehensive Cancer Center, found that 24
Full Post: Men who survive childhood leukemia have lower bone mineral density